Torrent Pharmaceuticals Ltd. benchmarking: Perfomance to industry peers

Financial

	Torrent Pharma	Cipla	Dr. Reddy's Lab
Operational Metrics
Pharmaceutical Sector
Number of ANDA's Filed in USA	172.0 .	282.0 .	362.0 .
Number of ANDA's Approved By USFDA	132.0 .	217.0 .	292.0 .
Domestic Sales Growth - YoY	12.3 %	6.8 %	9.1 %
R&D as a % of Total Sales	5.0 %	6.2 %	7.3 %
Financials
5 yr Average ROE	20.79 %	13.9 %	15.68 %
5yr average Equity Multiplier	2.16	1.25	1.41
5yr Average Asset Turnover Ratio	0.69	0.78	0.74
5yr Avg Net Profit Margin	13.95 %	14.31 %	15.18 %
Price to Book	15.89	3.92	3.1
P/E	60.24	22.68	18.31
5yr Avg Cash Conversion Cycle	-186.79 Days	-4.31 Days	74.48 Days
Inventory Days	54.98 Days	57.83 Days	76.14 Days
Days Receivable	40.18 Days	50.64 Days	95.44 Days
Days Payable	298.32 Days	105.99 Days	102.6 Days
5yr Average Interest Coverage Ratio	7.38	53.73	35.66
5yr Avg ROCE	25.78 %	19.36 %	21.82 %
5yr Avg Operating Profit Margin	30.49 %	23.02 %	23.61 %
5 yr average Debt to Equity	0.66	0.03	0.12
5yr CAGR Net Profit	8.83 %	17.0 %	23.71 %
5yr Average Return on Assets	9.73 %	11.19 %	11.24 %
Shareholdings
Promoter Holding	68.31 %	29.19 %	26.64 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-2.94 %	-4.42 %	-0.07 %
Change in Mutual Fund Holding (3 Yrs)	-2.83 %	7.05 %	-0.6 %

Business

	Torrent Pharma	Cipla	Dr. Reddy's Lab
Product Wise Break-Up	Product Wise Break-Up Domestic Formulations 42.15 US Formulations 20.71 Germany 13.15 Brazil 8.98 Contract Manufacturing 6.15 New ventures 0 Pharmaceuticals 0 Proprietary Products 0 Global Generics 0 0 Others 8.86	Product Wise Break-Up Brazil 0 Domestic Formulations 0 Contract Manufacturing 0 New ventures 6.32 Germany 0 0 US Formulations 0 Global Generics 0 Pharmaceutical 93.68 Proprietary Products 0	Product Wise Break-Up Brazil 0 Domestic Formulations 0 Contract Manufacturing 0 New ventures 0 Germany 0 Pharmaceutical 11.32 US Formulations 0 Formulations 86.8 Pharmaceuticals 0 Proprietary 1.88
Location Wise Break-Up	Location Wise Break-Up India 56.99 Germany 9.69 USA 9.69 Brazil 6.86 SAGA 0 Europe 0 Global API 0 Rest of the World 0 Emerging Markets 0 North America 0 Russia 0 Others 16.77	Location Wise Break-Up India 44.0 Brazil 0 USA 0 SAGA 13.0 North America 28.0 Russia 0 Global API 1.0 Germany 0 Europe 12.0 Emerging Markets 0 Rest of the World 0 Others 2.0	Location Wise Break-Up India 17.36 Brazil 0 USA 48.56 SAGA 0 North America 0 Russia 7.99 Global API 0 Germany 0 Europe 0 Emerging Markets 0 Rest of the World 0 Others 26.09
Acute vs Chronic	Acute vs Chronic Chronic 76.0 Acute 24.0 Sub - chronic 0	-	-
Therapeutic Area Break-Up	Therapeutic Area Break-Up Cardiac Science 25.0 Gastro Intestinal 17.0 CNS 15.0 VMN 11.0 Anti - Diabetes 10.0 Pain Management 7.0 Gynecology 2.0 Anti-Infective 2.0 Rest 2.0 Respiratory 0 Anti-Infective 0 Central Nervous System 0 Pain Management 0 Cardiovascular 0 Oncology 0 Gastrointestinal 0 Others 9.0	-	Therapeutic Area Break-Up Gastro Intestinal 0 Anti - Diabetes 0 Central Nervous System (CNS) 12.12 Cardiac Science 0 Pain Management 9.77 Gastro Intestinal 9.52 Oncology 27.53 CNS 0 Rest 0 Gynecology 0 Anti-Infective 6.48 Respiratory 7.04 VMN 0 Cardiac Science 6.65 Others 20.89
Asset Break-Up	Asset Break-Up India 94.39 USA 0.46 South Africa 0 United States 0 Switzerland 0 Others 5.15	Asset Break-Up South Africa 18.03 India 49.7 USA 28.99 United States 0 Switzerland 0 Others 3.28	Asset Break-Up South Africa 0 India 80.24 USA 0 USA 2.37 Switzerland 8.45 Others 8.94

Torrent Pharmaceuticals Ltd.

Torrent Pharmaceuticals Ltd.

Financial

Business

SIGN UP FOR FREE